Austin Kirschner

Radiation Oncologist MD PhD physician-scientist at Vanderbilt University Medical Center. Tweets are my own.

[Dr. Cathy Eng @CathyEngMD]

Happening today 8/21/2026 re: #kidneycancer #nashville @Marriott @VUMCDiscoveries @DrScottHaake @brian_rini @Sid423 @AKRadDoc @Merck @ExelixisInc

Link: https://t.co/xr7lbTs88k

#cancer #renalcellcarcinoma #cancerresearch @VUMChealth

[Austin Kirschner @AKRadDoc]

New review in Cellular Signalling: how prostate cancer evades radiation. We discuss key mechanisms of radioresistance—DDR pathways, AR signaling, hypoxia, TME—and highlight actionable targets to improve RT outcomes. https://t.co/Aw2dtSRkmS #ProstateCancer @VUMCRadOnc

[Austin Kirschner @AKRadDoc]

Low Dose Radiotherapy for Osteoarthritis adds to the management options available for this debilitating condition. @VUMCRadOnc

https://t.co/IRjpeb7U9e

https://t.co/sa9ATgxklD

[Austin Kirschner @AKRadDoc]

Exciting results of a randomized trial show benefits of low dose radiotherapy for knee osteoarthritis! https://t.co/CXjDsQbUWS

[Austin Kirschner @AKRadDoc]

Fantastic meeting discussing urologic cancer management! #UromigosLive24

[Vanderbilt Radiation Oncology @VUMCRadOnc]

Cheers to our graduating resident Dr. Dakim Gaines @gainesmdphd 🎓🎉. Wishing you all the best in your next chapter. You’ve made us all proud with your dedication and passion to patient care and equity, and we know you’ll continue to shine.
#radonc #graduation

[Woodson Smelser, MD @WSmelser]

Great overview in @NatRevUrol from @UrogerliMD and colleagues re: novel IO combinations, and additional brand new data from our published work with intravesical IO + oncolytic reovirus in murine models. @UroCancerMD @AKRadDoc

[Nature Reviews Urology @NatRevUrol]

Intravesical instillation with a PDL1 inhibitor, an oncolytic reovirus or the combination of the two in an orthotopic murine model of bladder cancer improves survival by generating an immuno-responsive TME.
https://t.co/9SPP0F8TXm
Also check our Review
https://t.co/lOkPGw8UGk

[Austin Kirschner @AKRadDoc]

Check out our survey about Incidentalomas found on radiotherapy planning CT simulation scans. https://t.co/g547tqcWEq

[Austin Kirschner @AKRadDoc]

New MRI technique can differentiate radionecrosis from recurrent brain tumor. Glad to be a part of this important work. https://t.co/znvJv1qmkA

[Austin Kirschner @AKRadDoc]

Eagerly awaited results of randomized RADICALS trial shows 2yr ADT is better at preventing Metastases than 6mo or no ADT when giving post-prostatectomy radiotherapy https://t.co/JULfLoPm5c

[Austin Kirschner @AKRadDoc]

Excited to share our case report of Radiation Fibrosis After Stereotactic Body Radiation Therapy for Osseous Metastases: A Case Report (Cureus) https://t.co/MKP44tTJLf

[Vanderbilt Radiation Oncology @VUMCRadOnc]

Really interesting animal model of radionecrosis by Dr. Kirschner’s group! Hopeful that this model will lead to a better understanding of CNS toxicity @AKRadDoc #radonc #CancerResearch #CNSOnc

[Vanderbilt Radiation Oncology @VUMCRadOnc]

New profile pic.. 😍😍😍#radonc #residents #faculty

[Austin Kirschner @AKRadDoc]

Excited to share a new model of brain radionecrosis in rodents using a clinical linear accelerator! https://t.co/DjCrVEnyDQ

[ASTRO @ASTRO_org]

New in the #RedJournal: Exploring the Use of Low-Dose Radiotherapy for Osteoarthritis through a comprehensive review including treatment planning suggestions, possible indications, and literature review @A_Dove5 @DrChowdharyMD @drbeckta @DrKyraWrites https://t.co/lTV6DROksl